HedgePath Pharmaceuticals, Inc.
HedgePath Pharmaceuticals, Inc. (HPPI) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 48 transactions totaling $28.3K, demonstrating a bearish sentiment with -$25.7K in net insider flow. The most recent transaction on Jan 15, 2019 involved a transaction of 362,121 shares valued at $0.
HPPI Insider Activity Summary
Who Is Buying HPPI Stock?
No significant insider buying has been recorded for HPPI in the recent period.
Who Is Selling HPPI Stock?
No significant insider selling has been recorded for HPPI in the recent period.
Is HedgePath Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for HPPI is bearish with an Insider Alignment Score of 5/100 and a net flow of -$25.7K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
HPPI Frequently Asked Questions
Understanding HPPI Insider Activity
Insider trading at HedgePath Pharmaceuticals, Inc. (HPPI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading HPPI stock, having executed 48 transactions in the past 90 days. The most active insider is Nicholas J. Virca (Executive), who has made 2 transactions totaling $2.1M.
Related Tools
Track HedgePath Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at HPPI file new Form 4 transactions